Pricing Log in Create free account
Friday 6 November 2026 Export TFX’s income statement to Excel — free account

Teleflex Incorporated

TFX Healthcare Medical Instruments & Supplies

Teleflex Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 17.2% from fiscal 2024.

Revenue
+28.9%
EPS
−17.3%
Free cash flow
+220.1%
Total debt
+47.7%

Quarter to June 2026, against a year earlier

152.16 2.29 +1.53%
Market cap
$6.5B
P/E
0.0×
Fwd P/E
37.4×
Dividend yield
0.89%
F-score
5/9
Altman Z
2.04
Beneish M
−2.21
Dividend safety
20/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Teleflex Incorporated (TFX) SEC filings, changes and red flags

Red flags

  • Officer departure

    Teleflex Incorporated reported the departure of an officer or director

    8-K filed · The filing · sec.gov

  • Impairment

    Teleflex Incorporated recorded a goodwill impairment of $403.9 million in fiscal Q3 2025

    10-Q filed · The filing · sec.gov

Filings

Form Period Filed What it reports Flags
10-Q Sep 30, 2026 P1I2: 28 added · 14 removed · 43 modified
P2I1A: no changes
8-K Nov 5, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Sep 8, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits Officer departure
8-K Aug 7, 2026 8.01 Other events
10-Q Jun 30, 2026 P1I2: 24 added · 9 removed · 37 modified
P2I1A: no changes
8-K Aug 6, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K/A Aug 3, 2026 9.01 Financial statements and exhibits
8-K Aug 3, 2026 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Jun 15, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
8-K Jun 8, 2026 5.02 Departure or appointment of directors or officers
8-K Jun 1, 2026 8.01 Other events; 9.01 Financial statements and exhibits
8-K Jun 1, 2026 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
8-K May 26, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
8-K May 15, 2026 5.07 Submission of matters to a vote of security holders
10-Q Mar 31, 2026
8-K May 7, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Apr 28, 2026 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
8-K Mar 27, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Mar 11, 2026 8.01 Other events
10-K Dec 31, 2025 1: 12 added · 17 removed · 35 modified
1A: 5 added · 6 removed · 34 modified
7: 47 added · 39 removed · 56 modified
8-K Feb 23, 2026 2.02 Results of operations and financial condition; 2.05 Costs of exit or disposal activities; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Jan 23, 2026 5.02 Departure or appointment of directors or officers
8-K Jan 7, 2026 2.02 Results of operations and financial condition; 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
8-K Dec 9, 2025 1.01 Entry into a material definitive agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Sep 28, 2025 Impairment
8-K Nov 6, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Jun 29, 2025
8-K Jul 31, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Mar 30, 2025
8-K May 1, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-K Dec 31, 2024
8-K Feb 24, 2025 1.01 Entry into a material definitive agreement; 2.02 Results of operations and financial condition; 2.03 Creation of a direct financial obligation; 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Sep 29, 2024
8-K Oct 31, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K Aug 1, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K May 2, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Feb 22, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.